Answers are grounded in this paper and cite their sources.
Tumor uptake of ¹⁸F-Fluciclovine correlated well with the established brain tumor imaging agent ¹¹C-Methionine but provided significantly higher image contrast. ¹⁸F-Fluciclovine may be particularly useful when the contrast MRI is non-diagnostic. Based on the data gathered, we were unable to determine whether Fluciclovine uptake was due solely to recurrent tumor or if inflammation or other processes also contributed.
No takes yet. Share an insight, caveat, or question.
Michaud et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: